Podcasts
Queue up something from ISHLT Voices to explore! Content includes in-depth review of studies from JHLT, a look back into the ISHLT history and archives, and insights from our colleagues in industry. Watch this space for more content to be added.
Round-table talks with the JHLT Editor-in-Chief and Digital Media Editors exploring contributors and studies from the Journal.
Look back in ISHLT's history with interviews and insights from years gone by.
-
DQS: The New Evolution of dd-cfDNA Testing and Noninvasive Rejection Monitoring, Presented by Natera26 June 2025A discussion on ISHLT Voices podcast hosted by Natera, where transplant cardiologists explore the evolving landscape of post-heart transplant care—particularly cell-free DNA technologies.
-
Unlocking Hyperimmunes - Emerging Clinical Data about Cytogam: Presented by Kamada9 September 2024 -
Explore Noninvasive Rejection Monitoring in Single Lung Transplantation; A SLAM Study Overview, Presented by Natera14 November 2024
A discussion on ISHLT Voices regarding the need for noninvasive surveillance options for single lung transplantation and the role that the Prospera Lung donor derived cell free DNA (dd-cfDNA) test can play
-
Experts Tackle Bronchiolitis Obliterans Syndrome Part Three15 November 2023ISHLT Voices returns with another podcast presented by Zambon USA exploring bronchiolitis obliterans syndrome (BOS).
-
Exploratory Evidence Supports Use of Donor-Derived Cell-Free DNA to Monitor Pediatric Heart Transplant Recipients18 October 2023In this episode of the ISHLT Voices podcast, Dr. Shri Deshpande, a cardiologist at the National Children’s Hospital in Washington, DC USA, discusses his work on improving the care of pediatric heart transplant patients.
-
Experts Tackle Bronchiolitis Obliterans Syndrome Part Two20 September 2023ISHLT Voices returns with another podcast presented by Zambon USA exploring bronchiolitis obliterans syndrome (BOS).
-
The Future of Bronchiolitis Obliterans Syndrome12 July 2022ISHLT Voices returns with another podcast presented by Zambon USA exploring bronchiolitis obliterans syndrome (BOS).